Support of multi-component, multi-disciplinary projects that
address important scientific questions relevant to AIDS prophylactic vaccine
discovery research.
The HIVRAD program is designed to fund projects that further
address hypotheses crucial to the design of an efficacious HIV/AIDS
prophylactic vaccine. Applications for five years of support should include
plans that have advanced past the exploratory stage and include preliminary
data. Less fully developed applications can request less than 5 years of
support to establish feasibility. Applications aimed at developing or
optimizing a specific vaccine platform should lay out a research pathway with
clear decision points. Extensive modeling of vaccine concepts in non-human
primates may be included.
Clinical studies involving human subjects or vaccine research
focused solely on therapeutic applications are not considered appropriate and
will not be funded under this FOA.
Letter of intent due date: May 13, 2012
Application budgets are
not limited, but need to reflect actual needs of the proposed project.
Award Project Period: Scope of the proposed project should
determine the project period. The maximum period is 5 years.
